Yttrium-90 Market Size, Share, Growth, Industry Analysis, By Type (Yttrium-90 Radioisotope and Yttrium-90 Micro Spheres), By Application (Medical Applications, Radiation Therapy and Cancer Treatment) and Regional Forecast to 2034.

Last Updated: 03 July 2025
SKU ID: 29827954

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

YTTRIUM-90 MARKET OVERVIEW

The global Yttrium-90 Market  size was valued at  USD 1.46 billion in 2025 and is expected to reach USD 1.56 billion in 2026, progressing steadily to USD 2.63 billion by 2034, exhibiting a CAGR of about 6.72% over the forecast period 2026-2034.

A radiation treatment that helps with treating the problem through the method of targeted radiation. Since this treatment is minimally invasive, it reduces the recovery time for the patients. As a result, the Yttrium-90 has become an important tool in nuclear medicine that is known for its effective results and the market for Yttrium-90 is expected to grow in the coming years due to its increased usage in the medical field.

YTTRIUM-90 MARKET KEY FINDINGS

Market Size and Share: The global market for Ytttium-90 was estimated at 1.36 billion USD in the year 2024 and with its growing demand in the medical field the market is expected to reach a projected value of 2.46 billion USD by 2033, reflecting a CAGR of 6.72% during the forecast period.

Key Market Driver: Increased cancer incidents are the key market drivers as it contributes to 52.3% of the market demand. This is closely followed by minimal invasive therapies accounting for 46.8% of the growth.

Major Market Restrain: Regulatory hurdles are the major market restrain as it impacts the market potential by 33.5%. In developing regions, it limits the access by 27.1%.

Emerging Trends: The emerging trend in the yttrium-90 market is the radioembolization technique as it represents 41.2% of the new applications. This is followed by combined therapies, which is raising by 36.4%.

Regional Leadership: North America leads the yttrium-90 market with 45.9% of the global market shares. This is followed by Europe and Asia-Pacific regions with 29.7% and 18.3% shares respectively.

Key Players: In the yttrium-90 market, the top 5 companies hold 63.2% market share and their main focus is on research & development and strategic partnership.

Market Segmentation: Among the yttrium-90 market segments, therapeutic applications dominate with 67.8% market volume, diagnostic uses hold 18.5% market volume and R&D holds 13.7% market volume.

Recent Development: In recent years, the adoption of Yttrium-90 microspheres has increased by 39.6% especially in the liver treatment.

LATEST TRENDS

Minimally invasive Procedure is the Latest Trend in the Yttrium-90 Market

Compared to the traditional chemotherapy and surgery, the yttrium-90 radioembolization technique is a less invasive technique and it involves treatment through targeted radiation without affecting the tissues nearby. This method reduces the recovery time for the patients as well. Due to these features, the minimal invasive procedure has become the latest trend in the yttrium-90 market.

US TARIFF IMPACT

When it comes to the yttrium-90 market the impact of tariffs is quite mixed. While the components needed for the yttrium-90 production and even the finished product may face an increase in the price due to tariffs. This in turn might result in the increase in the cost of the treatment. On the other hand, the pharmaceutical industry might not see any changes due to being exempted from the tariffs.

From this it can be inferred that the tariff has a significant effect on the market by distributing the supply, increasing the price of production and increasing the price of the treatment, leading to a massive amount of the patients opting out of this treatment thereby causing a decline in the market.

YTTRIUM-90 MARKET SEGMENTATION

BY TYPE

Based on Type, the global Yttrium-90 market is categorized into Yttrium-90 Radioisotopes and Yttrium-90 Micro Spheres.

Yttrium-90 Radioisotopes

This is a radiation therapy commonly employed for treating certain types of cancers. This treatment is known to be less invasive and causes few side effects. Due to its targeted treatment procedure it reduces the damage to the healthy tissues nearby and it is shown to prolong the time-to-progression and also for improving the quality of life for the patients. These features have made this treatment quite popular in the medical field. As such the market for the yttrium-90 radioisotopes is having a steady growth in recent years.

Yttrium-90 Micro Spheres

As the name suggests these are tiny radioactive beads that are commonly used in a procedure called radioembolization. This treatment is particularly used for treating liver cancers. They focus on targeting the tumor cells within the liver while still preserving the healthier cells and tissues in the liver.

Currently the market for yttrium-90 micro spheres is valued at 0.205 billion USD and with its rise in application with the medical field in the coming years, its market is expected to reach an estimated value of 0.397 billion USD by 2031.

BY APPLICATION

Based on Application, the global yttrium-90 market is categorized into Medical Applications, Radiation Therapy and Cancer Treatment.

Medical Applications

Yttrium-90 has quite a few applications in the medical field. The common ones include radioembolization treatment and radiation synovectomy. It is also being actively used in medical research to uncover more of its medical potential.

As of now due to the employment of yttrium-90 patients are able to get a better quality of life especially after a cancer treatment. This has greatly propelled the yttrium-90 market growth in recent years.

Radiation Therapy

In the radiation therapy, the yttrium-90 is used to treat cancers and tumors in various regions of the human body. One of the most common treatment methods is the radioembolization treatment which uses radioactive beads for targeted radiation treatment. Research is now being done to use yttrium-90 for other types of cancers as well.

With the increase in the success rate in using radiation therapy, its market within the yttrium-90 market has seen a significant rise in recent years and it is predicted to have an upward growth in the coming years as well.

Cancer Treatment

The main use of yttrium-90 is the treatment of cancer. It is known widely for specifically targeting the cancer cells during the treatment process thereby reducing the damage to the nearby healthy tissues. The radioembolization technique which is used to treat liver cancer is known for its minimal invasive procedure and for blocking the blood from flowing into the tumors. Yttrium-90 method of cancer treatment has resulted in the improvement of the quality of the patient’s life.

Due to the above mentioned reasons, research is being done extensively to use yttrium-90 for other forms of cancer as well. This has resulted in the considerable increase in the yttrium-90 market growth.

MARKET DYNAMICS

Market dynamics includes driving and restraining factor, opportunities and challenges stating the market conditions.

DRIVING FACTORS

Expanding Healthcare Industry is Driving the Market Growth

With the rapid development of the healthcare industry around the globe, the patients are able to get access to yttrium-90 related treatment quite easily. The yttrium-90 treatment has also gained popularity in the treatment of liver cancer as well, this coupled with the government initiatives for better healthcare has fueled the growth of the yttrium-90 treatment thereby resulting in the growth of the yttrium-90 market growth.

Rising Liver Cancer Rate Fueling the Market Growth

With the rising unhealthy diet among the global population, there has been a drastic increase in liver cancer as well. This results in the demand for radioembolization treatment which uses yttrium-90. Hence due to the rise of liver cancer among the global population has directly resulted in the growth of the yttrium-90 market growth.

RESTRAINING FACTOR

High Treatment Cost is Restraining the Market Growth

The yttrium-90 radioembolization treatment is considered as an advanced form of liver cancer treatment and as such the cost of this treatment is quite high. This coupled with the basic hospital costs along with medication could be quite daunting for the middle class patients and could deter the patients from opting this treatment leading to restrain in the market growth.

Market Growth Icon

Personalized Medication Opening New Opportunities for the YTTrium-90 Market

Opportunity

In recent years, there has been a growing adoption for personalized medication among the patients. This feature opens new opportunities for the personalized treatment method such as radioembolization, as it is treated by target radiation and can be tailored to the needs and severity of the disease.

Market Growth Icon

Emerging Therapies Challenging the Yttrium-90 Market

Challenge

The healthcare industry is one that is constantly evolving with new treatments and procedures being introduced continuously. New targeted therapies are being introduced due to repeated research. This creates a competition for the yttrium-90 related therapies and in turn challenges the growth of the yttrium-90 market.

YTTRIUM-90 MARKET REGIONAL INSIGHTS

NORTH AMERICA

The United States yttrium-90 market is considered as the leading player in the global scale. The growth in this region is mainly due to the advancement of modern technologies, increase in liver cancer among individuals and regulatory support.

In the year 2024, the US yttrium-90 market was valued at 1.22 billion USD and it is projected to reach 2.67 billion USD by 2033 mainly due to the development of the healthcare industry in this region.

EUROPE

The Europe yttrium-90 market is growing steadily in recent years and it holds 27.9% shares of the global yttrium-90 market share. The growth of the market in this region is fueled by increasing demand for targeted therapies and the overwhelming prevalence of cancer among the population.

Among the European countries, Germany holds the dominant position in the yttrium-90 market as well in nuclear medication. It is followed by France and Italy in the 2nd and 3rd position in the Europe region.

ASIA

The Asia yttrium-90 market is a new rising market with Asia-Pacific region being the key player in this region. Rapid growth of the healthcare industry especially in the developing countries and the rising demand for targeted therapies are the key factors fueling the market growth in this region.

Countries such as China, Japan, South Korea and India are the key players in the Asia-Pacific region and the market in this region is projected to reach 0.397 billion USD by 2031 with the help of these key players.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

The key industry players are also the dominant players in the global yttrium-90 market. They are responsible for keeping up with the latest trends in the market that results in the market growth recently. They invest heavily on the research and development to come up with latest updates or development or even new products to the global market. Key industry players are responsible for the smooth distribution of raw materials and end products to the manufacturers and end users. Key players constantly come up with new strategies to promote the market during the period of decline.

LIST OF KEY YTTRIUM-90 COMPANIES

Sirtex Medical Limited (Australia)

Boston Scientific Corporation (U.S.)

Eckert & Ziegler (Germany)

BK Biomedical (Canada)

Terumo Corporation (Japan)

Nordion (Canada)

Merit Medical Systems (U.S.)

Cook Medical (U.S.)

Medtronic (Ireland)

Q BioMed (U.S.)

KEY INDUSTRY DEVELOPMENT

2023: New clinical trials were done and the data obtained showed improved outcomes with resin microspheres and these data were published as well.

REPORT COVERAGE

This report covers the basis of the yttrium-90, its application in the medical field and its global market. It covers the latest trends in the market and its influence in the market growth. The impact of tariffs on the global market.

The report describes the segmentation of the yttrium-90 market and its contribution to the market growth. The driving factors and opportunities that boost the market growth on the global scale and the restraining factors and challenges that hinder the growth.

The report briefly covers the regional insight of the yttrium-90 market. The role of key industry players in the global market and the key industry development that took place recently in the market.

Yttrium-90 Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 1.46 Billion in 2025

Market Size Value By

US$ 2.63 Billion by 2034

Growth Rate

CAGR of 6.72% from 2025 to 2034

Forecast Period

2025 - 2034

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Yttrium-90 Radioisotope
  • Yttrium-90 Micro Spheres

By Application

  • Medical Applications
  • Radiation Therapy
  • Cancer Treatment

FAQs